NPI: 1831155662 · CHIPLEY, FL 32428 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/21/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/21/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,942 | $1.50M |
| 2019 | 18,614 | $2.48M |
| 2020 | 21,520 | $2.55M |
| 2021 | 9,418 | $659K |
| 2022 | 1,904 | $363K |
| 2023 | 2,553 | $86K |
| 2024 | 2,973 | $96K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,817 | 1,495 | $2.50M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 20,251 | 777 | $2.35M |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,564 | 759 | $1.28M |
| A4657 | Syringe, with or without needle, each | 2,357 | 978 | $479K |
| J1756 | Injection, iron sucrose, 1 mg | 4,160 | 644 | $408K |
| 83970 | 987 | 504 | $134K | |
| 85041 | 1,136 | 592 | $131K | |
| 85048 | 1,064 | 568 | $129K | |
| 83540 | 820 | 503 | $100K | |
| 83550 | 826 | 505 | $100K | |
| 82728 | 753 | 452 | $94K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 147 | 48 | $26K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 23 | 13 | $0.00 |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 19 | 12 | $0.00 |